« Previous
Next »
International Journal of Pediatric Otorhinolaryngology
Volume 74, Issue 4
, Pages 384-386
, April 2010
Glucocorticoids reduce nitric oxide concentration in middle ear effusion from lipopolysaccharide induced otitis media
References
- . The burden of otitis media. Vaccine. 2008;23(26):Suppl. 7:G2–4
- . Platelet-activating factor (PAF) induced cytokine production and otitis media with effusion (OME) in the rat middle ear. Auris Nasus Larynx. 2008;35(3):338–343
- . Murine model of interleukin-8-induced otitis media. Laryngoscope. 1997;107(10):1405–1408
- Effects of inhaled nitric oxide on inflammation and apoptosis after cardiopulmonary bypass. Chest. 2005;128(4):2910–2917
- . Concentration of nitric oxide metabolites in middle ear effusion. Int. J. Pediatr. Otorhinolaryngol. 2001;60(1):55–58
- Regulation of inducible nitric oxide production by cytokines in human thyrocytes in culture. Endocrinology. 1995;136(10):4261–4270
- Ascorbic acid reduces noise-induced nitric oxide production in the guinea pig ear. Laryngoscope. 2008;118(5):837–842
- . Effects of nitric oxide on morphology of isolated cochlear outer hair cells: possible involvement in sensorineural hearing loss. Otol. Neurotol. 2003;24(4):682–685
- . Role of nitric oxide in mediation of macrophage cytotoxicity and apoptosis. Cancer Metastasis Rev. 1998;17(1):39–53
- . Taurine attenuates aminoglycoside ototoxicity by inhibiting inducible nitric oxide synthase expression in the cochlea. Neuroreport. 2008;19(1):117–120
- . Glucocorticoid modulation of cytokine signaling. Tissue Antigens. 2006;68(1):1–12
- Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes. Pediatrics. 2006;118(3):e561–e569
- . An economic evaluation of two ototopical treatments for acute otitis media in tympanostomy tube patients. Value Health. 2006;9(4):219–226
- Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes. Pediatrics. 2004;113(1 Pt 1):e40–e46
- Molecular mechanisms underlying dexamethasone inhibition of iNOS expression and activity in C6 glioma cells. Glia. 2003;42(1):68–76
- Effect of 10 pharmacologic probes on mRNA levels of inducible nitric oxide synthetase and selected inflammatory cytokines in a rat model of acute otitis media. Acta Otolaryngol. 2002;122(3):255–261
- Effect of round window membrane application of nitric oxide on hearing and nitric oxide concentration in perilymph. Int. J. Pediatr. Otorhinolaryngol. 2003;67(6):585–590
- . Dexamethasone inhibits IL-1 beta gene expression in LPS-stimulated RAW 264.7 cells by blocking NF-kappa B/Rel and AP-1 activation. Immunopharmacology. 2000;48(2):173–183
- The role of inflammatory mediators in the pathogenesis of otitis media and sequelae. Clin. Exp. Otorhinolaryngol. 2008;1(3):117–138
- . Steroids in otolaryngology. Laryngoscope. 2008;118(9):1556–1560
- Effect of topical dexamethasone versus rimexolone on middle ear inflammation in experimental otitis media with effusion. Acta Otolaryngol. 2006;126(9):910–915
PII: S0165-5876(10)00011-X
doi: 10.1016/j.ijporl.2010.01.008
« Previous
Next »
International Journal of Pediatric Otorhinolaryngology
Volume 74, Issue 4
, Pages 384-386
, April 2010
